Literature DB >> 23225913

CRIg mediates early Kupffer cell responses to adenovirus.

Jeannie Q He1, Kenneth J Katschke, Peter Gribling, Eric Suto, Wyne P Lee, Lauri Diehl, Jeffrey Eastham-Anderson, Anusha Ponakala, Laszlo Komuves, Jackson G Egen, Menno van Lookeren Campagne.   

Abstract

Whereas adenoviral vectors are known to activate the complement cascade, leading to fixation of C3 proteins to the viral capsid, the consequences of this activation for viral clearance from the circulation are not known. Liver KCs, the macrophage population responsible for early uptake and elimination of many blood-borne pathogens, express CRIg, a complement receptor for C3 proteins. Here, we find that CRIg is important for the early elimination of C3-coated adenoviral vectors from the sinusoidal bloodstream by KCs. We further demonstrate that by acting as a critical receptor for adenovirus phagocytosis, CRIg plays an important role in regulating virus-induced KC death and depletion of these cells from the liver sinusoidal lumen. Our study thus identifies a critical pathway regulating KC function and survival in response to systemic viral infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23225913     DOI: 10.1189/jlb.0612311

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  17 in total

Review 1.  Innate immunity to adenovirus: lessons from mice.

Authors:  Svetlana Atasheva; Jia Yao; Dmitry M Shayakhmetov
Journal:  FEBS Lett       Date:  2019-12-08       Impact factor: 4.124

Review 2.  Immune Cell Trafficking to the Liver.

Authors:  Sulemon Chaudhry; Jean Emond; Adam Griesemer
Journal:  Transplantation       Date:  2019-07       Impact factor: 4.939

Review 3.  Immune surveillance by the liver.

Authors:  Craig N Jenne; Paul Kubes
Journal:  Nat Immunol       Date:  2013-09-18       Impact factor: 25.606

4.  Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement.

Authors:  Zhili Xu; Qi Qiu; Jie Tian; Jeffrey S Smith; Gina M Conenello; Takashi Morita; Andrew P Byrnes
Journal:  Nat Med       Date:  2013-03-24       Impact factor: 53.440

Review 5.  Innate immune surveillance of the circulation: A review on the removal of circulating virions from the bloodstream.

Authors:  Stephanie E Ander; Frances S Li; Kathryn S Carpentier; Thomas E Morrison
Journal:  PLoS Pathog       Date:  2022-05-05       Impact factor: 7.464

6.  Hexon modification to improve the activity of oncolytic adenovirus vectors against neoplastic and stromal cells in pancreatic cancer.

Authors:  Tanja Lucas; Karim Benihoud; Frédéric Vigant; Christoph Q Schmidt; Christoph Q Andreas Schmidt; Andreas Wortmann; Max G Bachem; Thomas Simmet; Stefan Kochanek
Journal:  PLoS One       Date:  2015-02-18       Impact factor: 3.240

Review 7.  Cre-ativity in the liver: transgenic approaches to targeting hepatic nonparenchymal cells.

Authors:  Stephen N Greenhalgh; Kylie P Conroy; Neil C Henderson
Journal:  Hepatology       Date:  2015-04-13       Impact factor: 17.425

8.  CRIg+ Macrophages Prevent Gut Microbial DNA-Containing Extracellular Vesicle-Induced Tissue Inflammation and Insulin Resistance.

Authors:  Zhenlong Luo; Yudong Ji; Hong Gao; Felipe Castellani Gomes Dos Reis; Gautam Bandyopadhyay; Zhongmou Jin; Crystal Ly; Ya-Ju Chang; Dinghong Zhang; Deepak Kumar; Wei Ying
Journal:  Gastroenterology       Date:  2020-11-02       Impact factor: 22.682

9.  Microbial DNA Enrichment Promotes Adrenomedullary Inflammation, Catecholamine Secretion, and Hypertension in Obese Mice.

Authors:  Hong Gao; Zhongmou Jin; Kechun Tang; Yudong Ji; Jorge Suarez; Jorge A Suarez; Karina Cunha E Rocha; Dinghong Zhang; Wolfgang H Dillmann; Sushil K Mahata; Wei Ying
Journal:  J Am Heart Assoc       Date:  2022-02-03       Impact factor: 6.106

Review 10.  Differential Location and Distribution of Hepatic Immune Cells.

Authors:  Maria Alice Freitas-Lopes; Kassiana Mafra; Bruna A David; Raquel Carvalho-Gontijo; Gustavo B Menezes
Journal:  Cells       Date:  2017-12-07       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.